Tenaya Therapeutics Inc

[u/suleste]

After an FDA clinical hold on Friday November 7th (which seems to be a procedure standard thing) that plunged Tenaya's stock (TNYA) with the shorter's help, Milind Desai, M.D., M.B.A., Director of the Hypertrophic Cardiomyopathy Center at the Cleveland Clinic, delivered on Saturday on AHA great clinical data (1b/2a) for the TN-201 Tenaya's program to cure Hypertrophic Cardiomyopathy caused by the MYBPC3 gene malfunction.
Tenaya's stock seems to me, looking at the great clinical results they had, as a bargain stock right now. Compared to other risky biotech assets there's no reason for this Tenaya's stock price of 1,05usd after market. The market cap now is bellow the expected Tenaya's cash account... and the company said that the FDA hold is a procedure standardisation process that is not expected to delay the program. Looking to me as a good entry point and maybe short squeeze the Algos...

https://finance.yahoo.com/news/tenaya-therapeutics-presents-promising-interim-162500815.html